11/14/2024
3:51 PM | ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/12/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:17 PM | Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/05/2024
10:44 AM | Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
10/31/2024
4:52 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
4:49 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
4:50 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
10/30/2024
5:36 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 424B5 | |
10/30/2024
5:24 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 424B5 | |
10/29/2024
8:27 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:00 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
11:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
09/20/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:16 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/19/2024
3:33 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q/A | |
08/19/2024
3:36 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:30 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-K/A | |
08/14/2024
4:12 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/14/2024
4:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:30 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:47 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:41 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
11:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
05/24/2024
3:02 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2024
6:36 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/15/2024
6:00 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
4:04 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:15 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G | |
Free ELDN Stock Alerts